Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The study is a prospective randomized study comparing safety and effectiveness of a
basal-bolus regimen with glargine once daily and glulisine before meals, a basal plus regimen
with glargine once daily and supplemental doses of glulisine, and sliding scale regular
insulin (SSI) on correction of insulin regimen for the hospital management of medical and
surgical patients with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Guillermo Umpierrez Guillermo Umpierrez, MD
Collaborators:
Medical University of South Carolina Sanofi Texas A&M University